These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 19260114

  • 1. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW, Yang SN, Liang JA, Lin FJ, Tsai MH.
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [Abstract] [Full Text] [Related]

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [Abstract] [Full Text] [Related]

  • 3. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, Huang JL, Chang SY.
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [Abstract] [Full Text] [Related]

  • 4. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS, Lim YC, Lee JS, Kim YH, Kim SH, Choi EC.
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [Abstract] [Full Text] [Related]

  • 5. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?
    Tsou YA, Hua JH, Lin MH, Tsai MH.
    ORL J Otorhinolaryngol Relat Spec; 2006 Jul; 68(4):206-12. PubMed ID: 16508339
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):796-802. PubMed ID: 19289261
    [Abstract] [Full Text] [Related]

  • 9. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA, Kligerman J.
    ORL J Otorhinolaryngol Relat Spec; 2008 Jul 01; 70(6):381-8. PubMed ID: 18984974
    [Abstract] [Full Text] [Related]

  • 10. Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation.
    Yang SN, Liao CY, Chen SW, Liang JA, Tsai MH, Hua CH, Lin FJ.
    Int J Radiat Oncol Biol Phys; 2011 Mar 15; 79(4):1096-103. PubMed ID: 20605362
    [Abstract] [Full Text] [Related]

  • 11. Hypopharyngeal cancer treatment based on definitive radiotherapy: who is suitable for laryngeal preservation?
    Chen SW, Tsai MH, Yang SN, Liang JA, Shiau AC, Lin FJ.
    J Laryngol Otol; 2008 May 15; 122(5):506-12. PubMed ID: 17931444
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 15; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct 15; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ.
    J Urol; 2008 Nov 15; 180(5):2019-23. PubMed ID: 18801542
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF, Yang AK, Xie RH, Chen ZH, Wu QL, Ou SM, Liu WW, Xia LP, Chen MY, Zhang JX, Wu JH.
    Ai Zheng; 2004 Nov 15; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [Abstract] [Full Text] [Related]

  • 19. Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer.
    Knegjens JL, Hauptmann M, Pameijer FA, Balm AJ, Hoebers FJ, de Bois JA, Kaanders JH, van Herpen CM, Verhoef CG, Wijers OB, Wiggenraad RG, Buter J, Rasch CR.
    Head Neck; 2011 Mar 15; 33(3):375-82. PubMed ID: 20629076
    [Abstract] [Full Text] [Related]

  • 20. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N.
    Ann Thorac Surg; 2007 Apr 15; 83(4):1265-72. PubMed ID: 17383324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.